ID1 and ovarian cancer: The inhibitor of DNA binding 1 (ID1), significantly increased in our platinum-resistant PDOs, has been described to induce autophagy and chemoresistance through the STAT3/ATF6-mediated signalling pathway in ovarian cancer [31].